This section is dedicated to healthcare providers interested in learning more scientific and clinical details about Biopharm’s products.
Biopharm Group, headquartered in Cairo, Egypt, constitutes two separate but complementing companies.
The dedicated research of an international team of scientists which started in 1986 led to the discovery and development of innovative clinically-proven natural products from plants. This paved the way for the establishment of Biopharm for Scientific Research and Pharmaceutical Manufacturing, an Egyptian company established in 1995 to develop, manufacture, and market pharmaceutical, nutraceutical, and cosmetic products.
Biopharm Research & Development Corporation Ltd., an Isle of Man, Great Britain company established in 1997 to conduct research in medicinal plants that have a history of traditional use in order to develop new commercially viable products.
Biopharm has since been engaged in R&D as well as submission for regulatory approval of unique generic pharmaceuticals, natural nutraceuticals, and cosmeceuticals in Egypt and elsewhere.
Biopharm’s state-of-the-art pharmaceutical manufacturing and R&D facility in 6th of October City, Egypt, started operations in November 2008. It was designed to conform to FDA and EU current Good Manufacturing Practices (cGMP) pharmaceutical standards.
The company adheres to the most rigid quality standards. Every ingredient in every formula is carefully sourced, scientifically analyzed, and vigorously tested to ensure purity, safety, and potency.